Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF - Get Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately 7,007 shares were traded during mid-day trading, an increase of 342% from the previous session's volume of 1,584 shares.The stock last traded at $22.80 and had previously closed at $23.41.
Hikma Pharmaceuticals Trading Down 2.1%
The business has a fifty day simple moving average of $25.70 and a 200 day simple moving average of $26.51. The company has a quick ratio of 0.72, a current ratio of 1.24 and a debt-to-equity ratio of 0.33.
About Hikma Pharmaceuticals
(
Get Free Report)
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
Before you consider Hikma Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hikma Pharmaceuticals wasn't on the list.
While Hikma Pharmaceuticals currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
